Clinical Trial: SWOG S2505

SWOG S2505

Status: New, Open

Phase III Randomized Study Testing Non-Inferiority of Short-Course Ultra-Hypofractionated Radiation (UHRT-5) Versus Standard Fractionation (RT-25) for Stage II-IIIB, Extremity, Resectable Soft Tissue Sarcoma

Eligible for screening study DCP 001